In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes-Reference-Cited by-同舟云学术

In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes

Published:2008-06 Issue:2 Volume:61 Page:227-231
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Campanile Floriana,Bongiorno Dafne,Borbone Sonia,Falcone Marco,Giannella Maddalena,Venditti Mario,Stefani Stefania

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference32 articles.

1. The Staphylococcus aureus genome;Baba,2004

2. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates;Biavasco;Antimicrob. Agents Chemother.,2000

3. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics;Billot-Klein;J. Bacteriol.,1996

4. Daptomycin activity against multi-resistant Staphylococcus haemolyticus bloodstream isolates from severe infections;Campanile,2006

5. Performance Standard for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S16;Clinical and Laboratory Standard Institute (CLSI),2006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New advances in management and treatment of cardiac implantable electronic devices infections;Infection;2023-11-24

2. Susceptibility Profile ofStaphylococcus epidermidisandStaphylococcus haemolyticusIsolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years;Microbial Drug Resistance;2016-06

3. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections;International Journal of Antimicrobial Agents;2015-12

4. Staphylococcus haemolyticus – an emerging threat in the twilight of the antibiotics age;Microbiology;2015-11-01

5. Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: New insights and evidence from the literature;Journal of Infection and Chemotherapy;2015-05